Related Experiment Video
Updated: Jun 22, 2026

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Flaviviral methyltransferase/RNA interaction: structural basis for enzyme inhibition
Mario Milani1, Eloise Mastrangelo, Michela Bollati
1Department of Biomolecular Sciences and Biotechnology, University of Milano, Milano, Italy.
Researchers identified a potent inhibitor for flavivirus methyltransferases, essential enzymes for virus replication and mRNA capping. This discovery offers a promising avenue for developing new antiviral drugs against diseases like Dengue and Yellow fever.
Area of Science:
- Virology
- Biochemistry
- Drug Discovery
Background:
- Flaviviruses cause severe diseases like Dengue and Yellow fever.
- The NS5 protein's methyltransferase is crucial for viral RNA capping and replication.
- RNA capping is vital for mRNA stability, protein synthesis, and virus survival.
Purpose of the Study:
- To develop a mechanistic model of flavivirus methyltransferase N7 methyl transfer.
- To identify potential antiviral compounds targeting flavivirus methyltransferases.
- To validate identified compounds through in vitro inhibition assays.
Main Methods:
- Utilized crystal structure of Wesselsbron flavivirus methyltransferase.
- Developed a mechanistic model for protein/RNA interaction.
- Employed in silico docking to screen for high-affinity compounds.
- Conducted in vitro assays to test inhibition of N7 and 2'O methyltransferase activities.
Main Results:
- A mechanistic model for N7 methyl transfer was established.
- In silico screening identified promising drug candidates.
- In vitro testing confirmed a high-potency inhibitor for Wesselsbron and Dengue virus methyltransferases.
Conclusions:
- A combined computational and experimental approach successfully identified a potent inhibitor.
- This inhibitor targets essential flavivirus methyltransferases.
- The findings pave the way for novel antiviral drug development against flaviviral infections.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly
Antiviral Nucleoside Inhibitors
Leaky Scanning
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

